Merrill Lynch downgrades MKS Instruments (MKSI) to Neutral
Merrill Lynch downgrades MKS Instruments (Nasdaq: MKSI) from Buy to Neutral
You May Also Be Interested In
- UPDATE: Canaccord Genuity Downgrades Globus Medical (GMED) to Hold
- Leerink Partners Downgrades Globus Medical (GMED) to Market Perform
- MKS Instruments Announces Upcoming Investor Events
Create E-mail Alert Related CategoriesDowngrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!